(Q48557680)

12 February 2018

title

Use of positron emission tomography to measure the effects of nalmefene on D1 and D2 dopamine receptors in rat brain. (English)

1 reference

12 February 2018

positron emission tomography

main subject

1 reference

Unterwald EM

1

1 reference

12 February 2018

Tsukada H

2

1 reference

12 February 2018

Kakiuchi T

3

1 reference

12 February 2018

Kosugi T

4

1 reference

12 February 2018

Nishiyama S

5

1 reference

12 February 2018

Kreek MJ

6

1 reference

12 February 2018

language of work or name

English

0 references

publication date

1 November 1997

1 reference

12 February 2018

published in

Brain Research

1 reference

12 February 2018

volume

775

1 reference

12 February 2018

issue

1-2

1 reference

12 February 2018

page(s)

183-188

1 reference

12 February 2018

Naltrexone reverses ethanol-induced dopamine release in the nucleus accumbens in awake, freely moving rats

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2897%2900931-1

Morphine and δ-opiate agonists locally stimulate in vivo dopamine release in cat caudate nucleus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2897%2900931-1

Catecholamine Biosynthesis in Brains of Rats Treated with Morphine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2897%2900931-1

Amphetamine induced decreases in (18F)-N-methylspiroperidol binding in the baboon brain using positron emission tomography (PET).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2897%2900931-1

Drugs abused by humans preferentially increase synaptic dopamine concentrations in the mesolimbic system of freely moving rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2897%2900931-1

Nalmefene: intravenous safety and kinetics of a new opioid antagonist

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2897%2900931-1

Local enkephalins tonically modulate dopamine release in the striatum: a microdialysis study.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2897%2900931-1

Visualization of multiple opioid-receptor types in rat striatum after specific mesencephalic lesions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2897%2900931-1

The neutral endopeptidase-24.11 (enkephalinase) inhibitor, SCH 32615, increases dopamine metabolism in the nucleus accumbens of the rat.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2897%2900931-1

Narcotic antagonists. 4. Carbon-6 derivatives of N-substituted noroxymorphones as narcotic antagonists

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2897%2900931-1

Naloxone reduces amphetamine-induced stimulation of locomotor activity and in vivo dopamine release in the striatum and nucleus accumbens

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2897%2900931-1

Neuroreceptor assay with positron emission tomography: equilibrium versus dynamic approaches

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2897%2900931-1

Difference in in vivo receptor binding between [3 H]N-methylspiperone and [3 H]raclopride in reserpine-treated mouse brain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2897%2900931-1

Opioids excite dopamine neurons by hyperpolarization of local interneurons.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2897%2900931-1

Regulation of somatodendritic dopamine release in the ventral tegmental area by opioids and GABA: an in vivo microdialysis study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2897%2900931-1

Difference in response of D2 receptor binding between 11C-N-methylspiperone and 11C-raclopride against anesthetics in rhesus monkey brain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2897%2900931-1

A double-blind, placebo-controlled pilot study to evaluate the efficacy and safety of oral nalmefene HCl for alcohol dependence

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2897%2900931-1

Differential effect of morphine on dopaminergic neurons in frontal cortex and striatum of the rat

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2897%2900931-1

Naltrexone and coping skills therapy for alcohol dependence. A controlled study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2897%2900931-1

Ketamine increases the striatal N-[11C]methylspiperone binding in vivo: positron emission tomography study using conscious rhesus monkey.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2897%2900931-1

Naloxone enhances cerebral reactive hyperemia in the rat.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2897%2900931-1

Enkephalin receptors on dopaminergic neurones in rat striatum

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2897%2900931-1

Dopamine microdialysis in the nucleus accumbens during acute and chronic morphine, naloxone-precipitated withdrawal and clonidine treatment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2897%2900931-1

Effects of intranigral substance p and neurokinin a on striatal dopamine release—II. Interactions with bicuculline and naloxone

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2897%2900931-1

Endogenous dopamine lowers the dopamine D2 receptor density as measured by [3H]raclopride: implications for positron emission tomography of the human brain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2897%2900931-1

Effect of intravenous heroin and naloxone on regional cerebral blood flow in the conscious rat.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2897%2900931-1

Stimulation of dopamine synthesis and release by morphine and D-Ala2-D-Leu5-enkephalin in the mouse striatum

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2897%2900931-1

Naltrexone in the treatment of alcohol dependence

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2897%2900931-1

Regional rat brain levels of 3,4-dihydroxyphenylacetic acid and homovanillic acid: concurrent fluorometric measurement and influence of drugs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2897%2900931-1

Phasic enkephalinergic modulation of nigrostriatal dopamine metabolism: potentiation with enkephalinase inhibitors.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2897%2900931-1

Quantification of neuroreceptors in the living human brain. I. Irreversible binding of ligands

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2897%2900931-1

Effects of endogenous dopamine on kinetics of [3H]N-methylspiperone and [3H]raclopride binding in the rat brain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2897%2900931-1

10.1016/S0006-8993(97)00931-1

7 January 2021

Identifiers

DOI

1 reference

12 February 2018

PubMed ID

9439841

1 reference

12 February 2018